Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Ridolfi · SciRah

Researcher profile · Semantic Scholar

L. Ridolfi

Share profile

L. Ridolfi — researcher profile on SciRah

h-index: 25
Works: 119
Citations: 2,251

Most-cited papers

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
O. Hamid, H. Schmidt, A. Nissan, L. Ridolfi +8 more
2011Journal of Translational Medicine530 citations Open access
Semantic Scholar
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy
R. Danielli, R. Ridolfi, V. Chiarion-Sileni, P. Queirolo +12 more
2011Cancer Immunology and Immunotherapy133 citations Open access
Semantic Scholar
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases
P. Queirolo, F. Spagnolo, P. Ascierto, E. Simeone +14 more
2014Journal of Neuro-Oncology118 citations Open access
Semantic Scholar
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients
L. Ridolfi, M. Petrini, A. Granato, G. Gentilcore +13 more
2013Journal of Translational Medicine80 citations Open access
Semantic Scholar
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial
G. Procopio, E. Verzoni, S. Bracarda, S. Ricci +6 more
2011British Journal of Cancer70 citations Open access
Semantic Scholar
Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens
V. Chiarion-Sileni, Michele Guida, L. Ridolfi, Antonella Romanini +6 more
2011British Journal of Cancer60 citations Open access
Semantic Scholar
Ipilimumab in advanced melanoma: reports of long-lasting responses
A. Farolfi, L. Ridolfi, M. Guidoboni, S. Nicoletti +6 more
2012Melanoma research54 citations
Semantic Scholar
Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study
M. Guida, S. Strippoli, M. Maule, P. Quaglino +16 more
2021ESMO Open51 citations Open access
Semantic Scholar
Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
R. Ridolfi, M. Petrini, L. Fiammenghi, M. Stefanelli +4 more
2006Journal of Translational Medicine43 citations Open access
Semantic Scholar
Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome
L. Ridolfi, M. Petrini, L. Fiammenghi, Anna Maria Granato +10 more
2011Melanoma research40 citations
Semantic Scholar
Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors
J. Bulgarelli, M. Tazzari, A. Granato, L. Ridolfi +13 more
2019Frontiers in Immunology38 citations Open access
Semantic Scholar
Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial.
L. Ridolfi, O. Bertetto, A. Santo, E. Naglieri +10 more
2011International Journal of Oncology38 citations Open access
Semantic Scholar
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
G. Schepisi, C. Gianni, M. Palleschi, S. Bleve +5 more
2023Cancers34 citations Open access
Semantic Scholar
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma
M. Guida, N. Bartolomeo, D. Quaresmini, P. Quaglino +16 more
2022Journal of Translational Medicine34 citations Open access
Semantic Scholar
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study.
L. Ridolfi, F. De Rosa, E. Petracci, E. Tanda +17 more
2020Journal of Geriatric Oncology34 citations
Semantic Scholar
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study
M. Guida, N. Bartolomeo, P. Quaglino, G. Madonna +15 more
2021Cancers31 citations Open access
Semantic Scholar
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised “proof-of-principle” phase II study
F. De Rosa, L. Ridolfi, R. Ridolfi, G. Gentili +14 more
2014Journal of Translational Medicine28 citations Open access
Semantic Scholar
Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial.
G. Procopio, E. Verzoni, S. Bracarda, S. Ricci +6 more
2013Annals of Oncology27 citations Open access
Semantic Scholar
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up
M. Caraglia, P. Correale, R. Giannicola, N. Staropoli +24 more
2019Frontiers in Oncology25 citations Open access
Semantic Scholar
Human embryo immune escape mechanisms rediscovered by the tumor.
L. Ridolfi, M. Petrini, L. Fiammenghi, A. Riccobon +1 more
2009Immunobiology25 citations
Semantic Scholar
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response
L. Ridolfi, F. De Rosa, R. Ridolfi, G. Gentili +5 more
2014Journal of Translational Medicine24 citations Open access
Semantic Scholar
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience
F. De Rosa, L. Ridolfi, L. Fiammenghi, M. Petrini +16 more
2017Melanoma research22 citations
Semantic Scholar
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)
L. Ridolfi, L. Gurrieri, N. Riva, J. Bulgarelli +23 more
2024Frontiers in Immunology21 citations Open access
Semantic Scholar
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma
J. Bulgarelli, C. Piccinini, E. Petracci, E. Pancisi +18 more
2021Frontiers in Immunology21 citations Open access
Semantic Scholar
Liver Metastases from Melanoma: Hepatic Intra-Arterial Chemotherapy. A Retrospective Study
A. Farolfi, L. Ridolfi, M. Guidoboni, C. Milandri +4 more
2011Journal of chemotherapy20 citations
Semantic Scholar
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
M. Rubatto, P. Fava, I. Stanganelli, S. Ribero +29 more
2023European Journal of Cancer18 citations Open access
Semantic Scholar
Erratum to “Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis”
L. Ridolfi, M. Petrini, L. Fiammenghi, A. Granato +11 more
2010Clinical and Developmental Immunology18 citations Open access
Semantic Scholar
Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis
L. Ridolfi, M. Petrini, L. Fiammenghi, A. Granato +11 more
2010Clinical and Developmental Immunology18 citations Open access
Semantic Scholar
The relative contribution of the decreasing trend in tumour thickness to the 2010s increase in net survival from cutaneous malignant melanoma in Italy: a population‐based investigation
F. Zamagni, L. Bucchi, S. Mancini, E. Crocetti +27 more
2022British Journal of Dermatology17 citations Open access
Semantic Scholar
Immunocheckpoint Inhibitors in Microsatellite-Stable or Proficient Mismatch Repair Metastatic Colorectal Cancer: Are We Entering a New Era?
L. Matteucci, A. Bittoni, Graziana Gallo, L. Ridolfi +1 more
2023Cancers14 citations Open access
Semantic Scholar
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series
L. Gurrieri, L. Mercatali, T. Ibrahim, V. Fausti +17 more
2023Journal of Neuro-Oncology13 citations Open access
Semantic Scholar
MicroRNAs and dendritic cell-based vaccination in melanoma patients
F. De Rosa, F. Fanini, M. Guidoboni, I. Vannini +4 more
2014Melanoma research13 citations
Semantic Scholar
Surgery and adjuvant therapies in the treatment of stage IV melanoma: our experience in 84 patients
F. Tauceri, G. Mura, M. Roseano, M. Framarini +2 more
2009Langenbeck's archives of surgery (Print)13 citations
Semantic Scholar
Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome
F. Venanzi, M. Petrini, L. Fiammenghi, E. Bolli +7 more
2009Cancer Immunology and Immunotherapy11 citations Open access
Semantic Scholar
Anti-CTLA-4 therapy in melanoma: Role of ipilimumab (MDX-010)
L. Ridolfi, R. Ridolfi
200911 citations
Semantic Scholar
In vitro CAR-T cell killing: validation of the potency assay
C. Piccinini, Silvia Carloni, C. Arienti, E. Pancisi +8 more
2024Cancer Immunology and Immunotherapy10 citations Open access
Semantic Scholar
Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center
E. Pancisi, A. Granato, E. Scarpi, L. Ridolfi +14 more
2022Vaccines9 citations Open access
Semantic Scholar
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)
L. Ridolfi, F. De Rosa, L. Fiammenghi, M. Petrini +12 more
2018BMJ Open9 citations Open access
Semantic Scholar
A randomized, open label, prospective study comparing the association between sorafenib (So) and interleukin-2 (IL-2) versus So alone in advanced untreated renal cell cancer (RCC): Rosorc Trial.
G. Procopio, E. Verzoni, S. Bracarda, S. Ricci +6 more
2016Journal of Clinical Oncology8 citations
Semantic Scholar
GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer.
C. Milandri, R. Polico, D. Garcea, A. Passardi +8 more
2011Hepato-Gastroenterology8 citations
Semantic Scholar
Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients
L. Ridolfi, G. Fiorentini, M. Guida, M. Michiara +5 more
2009Melanoma research8 citations
Semantic Scholar
Downstaging of a gastric GIST by neoadjuvant imatinib and endoscopic assisted laparoscopic resection.
Davide Cavaliere, A. Vagliasindi, Gianni Mura, M. Framarini +9 more
2007European Journal of Surgical Oncology8 citations
Semantic Scholar
The descriptive epidemiology of melanoma in Italy has changed - for the better.
L. Bucchi, S. Mancini, Emanuele Crocetti, L. Dal Maso +41 more
2023Italian journal of dermatology and venereology7 citations Open access
Semantic Scholar
Increased frequency of acute reactions to iodinated contrast media in cancer patients treated with anti-CTLA-4 immunomodulatory antibodies.
L. Ridolfi, F. De Rosa, E. Petracci, G. Gentili +6 more
2018Medical Hypotheses7 citations
Semantic Scholar
The European Ipilimumab Expanded Access Programme (EAP): Efficacy and Safety Data from the Italian Cohort of Patients with Pretreated, Advanced Melanoma
P. Ascierto, V. C. Sileni, M. Del Vecchio, M. Altomonte +6 more
20127 citations Open access
Semantic Scholar
Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial
J. Bulgarelli, C. Piccinini, E. Scarpi, G. Gentili +22 more
2025Journal of Translational Medicine6 citations Open access
Semantic Scholar
FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy
L. Fiammenghi, V. Ancarani, Tilman Rosales, J. Knutson +7 more
2010Journal of Translational Medicine6 citations Open access
Semantic Scholar
Reflections on Local Obstacles to Disparities Reduction in Juvenile Justice Systems and a Path to Change
James Bell, L. Ridolfi, Michaela C. Finley, C. Lacey +1 more
20096 citations
Semantic Scholar
Reversible, PET-positive, generalized lymphadenopathy and splenomegaly during high-dose interferon-alpha-2b adjuvant therapy for melanoma.
L. Ridolfi, D. Cangini, R. Galassi, A. Passardi +7 more
2008Journal of immunotherapy6 citations
Semantic Scholar
Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products.
A. Granato, E. Pancisi, C. Piccinini, M. Stefanelli +16 more
2024Cytotherapy5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Ridolfi×20
Invite
R. Ridolfi — researcher profile on SciRah
M. Guidoboni×19
Invite
M. Guidoboni — researcher profile on SciRah
M. Petrini×18
Invite
M. Petrini — researcher profile on SciRah
A. Granato×15
Invite
A. Granato — researcher profile on SciRah

×15

Invite

E. Pancisi — researcher profile on SciRah

Invite

F. De Rosa — researcher profile on SciRah

V. Ancarani×12

Invite

V. Ancarani — researcher profile on SciRah

L. Fiammenghi×11

Invite

L. Fiammenghi — researcher profile on SciRah

Invite

E. Scarpi — researcher profile on SciRah

A. Riccobon×11

Invite

A. Riccobon — researcher profile on SciRah

J. Bulgarelli×9

Invite

J. Bulgarelli — researcher profile on SciRah

Invite

F. Tauceri — researcher profile on SciRah